IDiyas

For the Inventor, By the Inventor

Pessac, France

Henri Pontagnier

USPTO Granted Patents = 15

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:

goldMedal11 out of 12 
 
Societe Cortial, S.a.
 patents
silverMedal3 out of 8 
 
Laboratoires Sarget
 patents
bronzeMedal1 out of 3 
 
Societe Cortial
 patents

Years Active: 1982-1989

Loading Chart...
15 patents (USPTO):Explore Patents
1. 4818772 - Derivatives of 4-aminoethoxy-5-isopropyl-2-methylbenzenes: methods of (1989-04-04),
2. 4760139 - Method of preparing D-ribose (1988-07-26),
3. 4758561 - N-substituted 2-aminomethylene-1,3-indanediones for treating arterial (1988-07-19),
4. 4757067 - Therapeutic application of N-substituted (1988-07-12),
5. 4721715 - Derivatives of 4-(arylpiperazinyl-ethylaminoethoxy) phenol useful for (1988-01-26),
6. 4698343 - (Alkoxy-2)phenylpiperazines having alpha-1 and beta blocking properties (1987-10-06),
7. 4668681 - 2-(4-Phenylpiperazinylethyl) anilines (1987-05-26),
8. 4605768 - 1-cycloalkylamino-3-t-butylamino-2-propanols, a method of preparing the (1986-08-12),
9. 4600788 - 4'-flavonecarboxylic acids and pharmaceutically acceptable derivatives (1986-07-15),
10. 4591600 - 3-hydroxyflavones: their preparation and therapeutic application (1986-05-27),
11. 4590193 - 3-(2-(4-phenylpiperazinylethyl)anilino)-isobenzofuranones, their method (1986-05-20),
12. 4499090 - N-(5-aminomethyl-2-oxazolin-2-yl)-N'-phenylureas, compositions and use (1985-02-12),
13. 4497812 - 2-Amino-5-aminomethyl-2-oxazolines, compositions and use (1985-02-05),
14. 4335113 - Triterpenic saponin having pharmacological potency (1982-06-15),
15. 4333938 - Imino derivatives of 5-aminobenzodioxole-1,3 which are useful as (1982-06-08),

Title: The Innovative Contributions of Henri Pontagnier

Introduction: Henri Pontagnier, a notable inventor based in Pessac, France, has made significant strides in the field of chemical innovations. With a remarkable portfolio of 15 patents, Pontagnier's work primarily focuses on pharmaceutical compounds and methods that reflect his expertise and dedication to research.

Latest Patents: Among his latest patented inventions, Pontagnier has developed derivatives of 4-aminoethoxy-5-isopropyl-2-methylbenzenes, showcasing compounds with alpha 1-blocking activity. These compounds are characterized by their specific formulas where R1 can be --H, --CH3, or --COCH3, R2 is either --H or CH3, and R3 includes various substituents, such as halogen or --OH. Additionally, Pontagnier has introduced a novel method for preparing D-ribose, which involves synthesizing a 1,5-di-O-alkyl derivative of D-xylofuranose and executing a series of chemical transformations. These methods culminate in the production of D-ribose through cis-hydroxylation followed by acid hydrolysis.

Career Highlights: Henri Pontagnier's career has been marked by his association with notable companies such as Société Cortial and Laboratoires Sarget. His innovative approach and commitment to advancing pharmaceutical sciences have established him as a key figure in his field.

Collaborations: Throughout his career, Pontagnier has collaborated with several esteemed colleagues, including Claude Feniou and Gisele Prat. These partnerships have contributed to the development of his patents and have fostered a collaborative environment for innovation.

Conclusion: Henri Pontagnier's impressive array of patents and his ongoing contribution to the field highlight the importance of innovation in pharmaceuticals. His work not only showcases his inventive spirit but also plays a crucial role in advancing medical science and improving health outcomes. As he continues to innovate, the impact of his inventions will undoubtedly extend beyond the laboratory.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…